Thanks for reading Hot Topics in Primary Care.

Please complete the following for certification.

Q1I am a(n)...
 MD/DO NP PA Other
     
Q2
 
Q3How many years have you been in practice?
 1-5 6-10 11-15 16-20 Over 20
      
Q4Number of patients do you see per month with...?
 1-10 11-20 21-30 31-40 41-50 Over 50
 CKD     
 Anemia in CKD     
Q5Please describe your practice setting:
 Solo Practice Group Practice Hospital Setting Clinic Other
      
Q6
 
Q7Please rate the following:
 Unsatisfactory Needs Improvement Average Above Average Excellent
 Degree to which educational expectations were met    
 Material was relevant to my practice    
 Effective Author    
 Overall Article    
Q8Please rate your ability to achieve the Learning Objectives below:
 Not at all Somewhat Mostly Completely
 Discuss methods to improve recognition of anemia in CKD   
 Explain the importance of early management of anemia to reduce symptoms and adverse outcomes in patients with CKD   
 Implement appropriate treatment for patients with anemia in CKD who can be adequately managed in the primary care setting   
 Describe evidence for emerging agents being studied in clinical trials for anemia in CKD   
Q9As a result of what you have learned during this program, will you change your practice behaviors?
 Definitely Not Unlikely Not Sure Probably Absolutely
      
Q10What will you change?
 
Q12What barriers do you see to change?
 
Q13
 
Q14Did the content contribute valuable information that will assist in improving patient outcomes?
 Strongly Disagree Disagree Neutral Agree Strongly Agree
      
Q15What was your level of expertise on this topic?
 None Little Some Considerable Extensive
 Before this presentation    
 AFTER this presentation    
Q16Do you believe the activity was fair and balanced, free from commercial influences?
 Yes No
   
Q17Did the program increase your competence?
 Yes No
   
Q18Which of the following is correct in diagnosing anemia in CKD?
 
Q19Which of the following is unique to the investigational class of agents, hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHIs) compared to erythropoiesis-stimulating agents (ESAs) for anemia in CKD?
 
Q20How confident do you feel in your answer to the previous question?
 Not at all confident Somewhat confident Confident Very confident
 ..   
Q21
 

       

 
dividing line